RSS feed

Focus Researcher: Guillaume Bassez at Myology 2016

Guillaume Bassez (Henri Mondor university hospital) talks about the results of his researches.

Focus Researcher: Bernard Jasmin at Myology 2016

Bernard Jasmin (University of Ottawa) discusses the factors enabling the modification of myotonic dystrophy.

Focus Researcher: Caroline Le Guiner at Myology 2016

Caroline Le Guiner (Biotherapies Institute for Rare Diseases) discusses the development of products for gene therapy in Duchenne muscular dystrophy.

Live from Myology 2016: Day 3

A summary of the third day at Myology 2016 in Lyon! Watch the testimonies of Nathalie Goemans (Hôpitaux Universitaires, Louvain), Aymeric Ravel-Chapuis (University of Ottawa), Géraldine Honnet (Biotherapies Institute for Rare Diseases) and Bernard Brais (McGill University, Québec).

Focus Researcher: Jerry Mendell at Myology 2016

Jerry Mendell told us about gene therapy in spinal muscular atrophy.

Focus Researcher: H. Lee Sweeney at Myology 2016

H. Lee Sweeney discusses the difficulty of having drugs approved for Duchenne Muscular Dystrophy.

Focus Researcher : Ichizo Nishino at Myology 2016

Ichizo Nishino explains his successful results for Nonaka myopathy (GNE).  

Myology 2016 – Day 3: Focus on therapeutics on trial or being developed for neuromuscular diseases

Wednesday opened on a symposium based on the development of innovative therapies, which make a new, booming type of medicine. Because the first drug candidates developed so far are only “prototypes”, researchers and doctors are building a strategy to tackle the disease on all fronts. Matthew Wood from Oxford University (UK) restored the expression of … [Read more]

Focus researcher : Matthew Wood at Myology 2016

Matthew Wood discusses the challenges of developing gene therapy

Live from Myology 2016: Day 2

A summary of the second day at Myology 2016 in Lyon! Discover the testimonies of Denis Furling (Institute of Myology),Claire Legay (University Paris Descartes), Laurent Schaeffer (NeuroMyoGène Institute), Bénédicte Chazaud (NeuroMyoGène Institute), Jordan Mecca (Institute of Myology) and Pascal Maire (Cochin Institute).